Global Pricing Innovations supports price decision-making through data-driven insights and bespoke analytical solutions. GPI tools and services maximize clients’ price and value understanding and ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...